Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 11/15/21 (What's New)

Summary

  • Current NCCN guidelines emphasize importance of smoking as risk factor for anal carcinoma with risk increased ~ 8 times for smokers versus nonsmokers [guideline:  NCCN HIV Cancer][NCCN Anal]
  • 9-valent human papillomavirus vaccine indicated for prevention of anal cancer and associated precancerous lesions due to HPV types 6, 11, 16, and 18, 31, 33, 45, 52, and 58 in people 9 through 45 years of age
  • AIN may be treated with topical agents and/or ablative therapy,[Abbasakoor 2005; Stier 2013] including infrared coagulation

Action required

Keywords: Cancer, Sexually Transmitted Diseases

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.